Brief: NKgen Biotech And Hekabio Enter Into Strategic Partnership
17/07/2025 23:20
July 17 (Reuters) - NKGen Biotech Inc NKGN.PK: NKGEN BIOTECH AND HEKABIO ENTER STRATEGIC PARTNERSHIP TO BRING NOVEL NK CELL THERAPY TO JAPAN Source text: ID:nGNX7rzRdW Further company coverage: NKGN.PK
Recent news on Nkgen Biotech
See all newsBrief: Nkgen Biotech Expands Clinical Trial Site Network For Alzheimer’S Disease Program Across US
Brief: NKgen Biotech And Hekabio Enter Into Strategic Partnership
Brief: Nkgen Biotech Announces International And U.S. Expansion Of Phase 1/2A Troculeucel Alzheimer’S Trial
Brief: Nkgen Biotech Announces Administration Of First Dose Of Troculeucel To Stroke Patient Under FDA-Cleared Compassionate Use Program
Brief: NKGen Biotech Announces Administration Of First Dose Of Troculeucel To Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program